ClinicalTrials.Veeva

Menu

Predisposing Factors Associated With Chemotherapy Toxicity in Elderly Cancer Patients

M

Mahidol University

Status

Unknown

Conditions

Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT02317757
559/2557(EC3)

Details and patient eligibility

About

These days, there is higher proportion of elderly cancer patients. Most of them have comorbidities, borderline performance status and nutritional status. The discontinuation of chemotherapy due to unbearable toxicities was not uncommon. Comprehensive geriatric assessment might be beneficial in selection of suitable elderly patients for chemotherapy administration.

Full description

The patients with the age more than 70 years old who scheduled for chemotherapy were enrolled. Geriatric assessment was performed before starting chemotherapy. The toxicity will be recorded prospectively. Predisposing factors of grade 3 and 4 toxicity will be reported.

Enrollment

150 estimated patients

Sex

All

Ages

70+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • more than 70 years of age
  • plan to receive first cycle of chemotherapy
  • histologically or cytologically proved of cancer

Exclusion criteria

  • patients who have concurrent chemoradiotherapy
  • patients who received local chemotherapy

Trial design

150 participants in 1 patient group

cancer patients receiving chemotherapy
Description:
Patients who are older than 70 years old receiving chemotherapy

Trial contacts and locations

1

Loading...

Central trial contact

Suthinee Ithimakin, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems